valueequityanalysis.com

Independent, business-by-business valuations built from company filings — owner earnings, a ten-year outlook, and a bear / base / bull range. Search a ticker to see our estimate of what the business is worth.

Not investment advice. We are not registered investment advisers, and the people behind this site may hold or trade positions in companies analyzed here. Full disclosures.

American National Group Inc. (ANG-PD) stock intrinsic value fair value estimate & owner earnings analysis

Margin of safety$17.50 ComplexityHigh Updated
$22.90 $27.64
bear $22.90 base $26.08 bull $27.64 margin of safety $17.50 market price* $23.51
WHAT THIS SECURITY IS. American National Group is a large US life and annuity insurer owned by Brookfield (Brookfield Wealth Solutions holds all 10,000 common shares). It combines American National Insurance Company (Texas), American Equity Investment Life (Iowa), Eagle Life and Bermuda reinsurers, with about $132 billion of assets at June 30, 2026. Because the common stock is wholly owned and not traded, the only publicly traded equity is the 7.375% Fixed-Rate Non-Cumulative Preferred Stock, Series D, issued January 10, 2025 (12,000 shares of $25,000, sold as 12 million depositary shares of $25 each, net proceeds $292 million). This analysis values that preferred. It pays $1.84 a year per $25 depositary share, quarterly on January, April, July and October 15 - but only when declared, and a skipped dividend is lost forever (non-cumulative). It has no maturity and holders can never demand repayment. The company may redeem at $25 on or after January 15, 2030, or earlier (in whole) after a rating-agency or regulatory-capital event. The value of the preferred therefore rests on three things: whether dividends keep being declared, when it is redeemed, and whether the $25 is ever at risk. HOW WELL COVERED IT IS. The group earned net income of $397 million in 2023, $680 million in 2024 and $540 million in 2025, and $211 million in the first half of 2026. Operating cash flow was $1.19 billion, $2.52 billion and $2.78 billion in 2023-2025 (for an annuity writer this figure includes large policy and reinsurance flows and is not a clean measure of distributable earnings, so we lean on net income and statutory dividend capacity instead). Against that, the Series D costs about $22 million a year - roughly 4% of a normal year's net income. Ahead of the preferred sit about $2.95 billion of senior borrowings and $500 million of 7.000% junior subordinated notes due 2055 issued August 2025; total holding-company debt was about $3.2 billion at year-end 2025, with cash interest of $158 million in 2025. Beneath the preferred is the common equity cushion: $9.7 billion at December 31, 2025 and $8.7 billion at June 30, 2026. In 2026 the subsidiaries can pay ordinary dividends to the holding company without regulatory approval of up to $276 million (American Equity, Iowa), $242 million (American National Insurance Company, Texas) and $659 million (Freestone Re, Bermuda) - about $1.2 billion of capacity against roughly $180 million of interest plus preferred dividends. The insurers are rated A (Excellent) by A.M. Best. WHAT HAS CHANGED. Since our previous look, the June 2026 quarterly report showed equity falling $1.0 billion in six months: about $660 million from unrealized investment losses (bond values falling with higher rates) and about $540 million paid up to Brookfield, after $1.2 billion was upstreamed in 2025. The business itself is earning steadily, but the owner is steadily taking capital out, and the preferred holder has no say over that. That is the main thing that can erode the cushion beneath the preferred, and it weighs on our bear case. Brookfield has also shown it redeems this kind of paper when cheaper funding is available: the inherited 5.95% Series A was redeemed in February 2025 (funded by this Series D) and the 6.625% Series B in October 2025 (funded by the 2055 notes). THE CASES. Values are the present value of the depositary share's own payments. Base ($26.08): every dividend is paid and the company redeems at $25 on the first call date, January 15, 2030 - the pattern Brookfield followed with Series A and Series B. Bull ($27.64): dividends continue and redemption is postponed to 2036; the company has shown it will refinance, but if its funding costs stay at or above the 7.0-7.375% it is paying now (its August 2025 junior notes were priced at 7.000%), leaving the preferred outstanding is the rational choice. Bear ($22.90): a credit downturn of the kind life and annuity insurers went through in 2008-2010 - when several (Hartford, Lincoln, Genworth) cut or suspended common and holding-company distributions as investment losses and capital requirements hit - leads the board to skip twelve quarterly dividends (2028 through 2030) to preserve capital; skipped dividends are lost because the shares are non-cumulative; payments resume in 2031 and the shares are not redeemed until 2036. We do not model loss of the $25 itself: the insurer's equity of $8.7 billion would have to be wiped out first - a loss more than four times the 2008-era peak losses as a share of capital for comparable annuity writers - and the preferred ranks ahead of all of it. In each case the business behind the security is worth far more than the $3.2 billion of debt ahead of it plus the $300 million preferred; the preferred is fully covered in all three. WHAT COULD MAKE THIS WRONG. (1) Brookfield continues to upstream capital faster than the group earns it, thinning the cushion; (2) a severe credit loss in the private credit, commercial mortgage and structured assets that Brookfield-managed insurers favor; (3) an early redemption at $25 (or $25.50 after a rating-agency event) would cap the return from any price above par. MARGIN-OF-SAFETY PRICE. We are confident about the earnings power covering this dividend - $22 million against $400-700 million of annual net income and $1.2 billion of approved-free dividend capacity - and less confident about how much capital Brookfield leaves behind. The worst plausible outcome is not loss of principal but a multi-year dividend suspension while the owner rebuilds capital, during which the price could fall well below par with nothing paid. The structure survives that: there is no maturity to refinance, and the junior notes and senior debt are long-dated. The return from a fixed $1.84 coupon and a $25 ceiling is limited, so a 20% annual return requires a low price. At $17.50, the coupon is about 10.5% a year in cash; if the shares are redeemed at $25 in January 2030 (the base case), the implied annual return is about 21%; if instead they stay outstanding and return to around par within two to three years, the implied return is also near 20%. If the dividend is suspended, the $25 claim still sits ahead of $8.7 billion of common equity. Above about $18 the 20% target depends on an early call or a quick re-rating, which cannot be counted on, so the margin-of-safety price is $17.50. The previously published price was set on a different basis and is not comparable.
Fiscal yearOwner's earningsMethodology
2023 $13.68 ▼
American National Group Inc. (CIK 1039828) was taken private by Brookfield Reinsurance in a May 2022 all-cash merger; common stock has had zero public float since (EntityPublicFloat=$0 as of mid-2025) and was consolidated to just 10,000 shares held by the Brookfield-affiliated parent in a 2024 reorganization, so no economically meaningful common share count exists after FY2023 (dividing owner earnings by 10,000 shares produces a figure in the hundreds of thousands per share, an artifact of private ownership, not operating performance -- FY2024/FY2025 are deliberately left unpopulated here rather than write a distorting figure into a shared metrics table). FY2023 is the last year with a genuine share count (80,952,270 diluted, per FY2023 10-K, accession 0001039828-24-000020) and is used as the last available common-equivalent data point, on the current (LDTI-restated) cash-flow basis: CFO=$1,186M (restated; FY2024/FY2025 10-Ks both report this figure for FY2023, vs. $3,940M as originally filed pre-LDTI-adoption -- the later, restated figure is used per house convention). Capex=$50.1M and SBC=$29.3M (both per FY2023 10-K, not materially affected by the LDTI restatement). Working-capital/reserve movements are already embedded in CFO for an insurer of this type and are not separately backed out given their immateriality relative to the ~40x+ dividend coverage this analysis turns on (see Analysis record). Maintenance capex = total capex ($50.1M) since this is an asset-light insurance operation with no meaningful growth-capex component. OE = 1,186 - 50.1 - 29.3 = $1,106.6M; OE/diluted share = 1,106.6M / 80,952,270 = $13.67/share. The investable security at this CIK is the 7.375% Series D Non-Cumulative Preferred Stock (NYSE: ANG-PD, $25,000 liquidation preference/share, $25.00/depositary share), valued directly in the Analysis record rather than off this common-equivalent figure.

Owner's earnings per share by fiscal year, most recent first. Tap a row to see how that figure was calculated, including the source filing.

Sales geography
United States (all regions, with Texas and Iowa-domiciled insurers selling nationally through independent agents and banks); Bermuda reinsurance
Historical growth strategy
Growth by acquisition and combination under Brookfield ownership: Brookfield Reinsurance bought American National in 2022 for cash, then folded in American Equity Investment Life (acquired 2024) to build a large fixed and fixed-index annuity platform, alongside steady organic sales of annuities, life insurance and property-casualty policies through agents and bank channels, and reinsurance through Bermuda affiliates.
Chart analysis
The Series D depositary shares have traded since January 2025 in a narrow band around their $25 par, behaving like a fixed-income instrument rather than a stock: price drifts inversely with long-term interest rates and credit spreads, with little trend of its own. A chartist would see a range-bound, low-volatility chart with support a little below par and resistance just above it, capped by the January 2030 call at $25, and would note regular small drops around each quarterly ex-dividend date.
Competitors

Companies we consider competitors of ANG-PD. Tap a ticker to open our analysis of that company in a new tab.

Circle of competence

We don't have circle of competence information for this company yet.